TAGLN
Overview
TAGLN (transgelin, also known as SM22-alpha) is a smooth-muscle actin-binding protein that marks neural-crest-derived and mesenchymal cell lineages. In cancer genomics, TAGLN has emerged as a transcriptomic marker of the low-UV-burden (LowMut) subpopulation of normal melanocytes, which are characterized by neural-crest/stem-like gene expression programs distinct from the differentiated/pigmented high-UV-burden (HighMut) subpopulation.
Alterations observed in the corpus
- TAGLN is transcriptionally upregulated in LowMut melanocytes (bottom UV-burden quartile) compared to HighMut melanocytes in a single-melanocyte multi-omics study (297 clonally-expanded cells, 31 donors); LowMut cells are enriched for smooth-muscle/neural-crest genes including TAGLN, MYL9, MYLK, SGCE, and HACD1 PMID:39975212.
- TAGLN expression defines the neural-crest/stem-like transcriptional state of LowMut melanocytes, which carry predominantly clock-like SBS1/SBS5 mutational signatures rather than UV-attributable SBS7 PMID:39975212.
- Mesenchymal-transition transcript up-regulated in pretreatment melanoma tumors that failed to respond to anti-PD-1 therapy; co-enriched within the IPRES (innate anti-PD-1 resistance) transcriptional signature PMID:26997480.
Cancer types (linked)
- SKIN — TAGLN is a LowMut-state marker in normal cutaneous melanocytes from non-lesional skin adjacent to melanoma; no direct somatic driver role is established PMID:39975212.
Co-occurrence and mutual exclusivity
- Co-expressed with other LowMut markers: VCAN, FBN1, PALLD, ITM2A, MYL9, MYLK, SGCE, HACD1, SEMA3C, TCF4, DAAM2, RGMB, NTNG1 — genes recapitulating neural-crest lineage fates PMID:39975212.
- Mutually exclusive expression with HighMut markers (HMOX1, ABCC2, MC1R, HERC2, LIPA, HLA-DPA1) within the same biopsy PMID:39975212.
Therapeutic relevance
- No drug targeting TAGLN is described in this corpus. The LowMut/neural-crest state marked by TAGLN is proposed as a reservoir of UV-protected melanocytes that could theoretically be leveraged for tissue rejuvenation, but no therapeutic intervention is validated PMID:39975212.
Open questions
- Whether TAGLN-high (LowMut/stem-like) melanocytes are the cell-of-origin for melanoma subtypes with low UV-mutation burden remains untested PMID:39975212.
- The causal direction of TAGLN expression in defining the LowMut niche vs. being a downstream consequence of follicular residence is not established PMID:39975212.
Sources
This page was processed by crosslinker on 2026-05-04. - PMID:26997480
This page was processed by wiki-cli on 2026-05-14.